Revenue grew 7% year-over-year, with all segments contributing and non-Rx business reaching profitability. Teleclinic doubled revenues, and a CHF 200 million capital raise is planned to support Rx growth and refinance debt. Guidance will be updated post-Q1 results.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.